Chemical inhibitors of D11Wsu47e can act through various mechanisms that lead to the functional inhibition of this protein by targeting pathways it is involved in. Acetaminophen, Aspirin, and Ibuprofen are known to inhibit COX enzymes, which are responsible for the production of prostaglandins. These prostaglandins may play a role in the functional activity of D11Wsu47e. By decreasing the synthesis of prostaglandins, these inhibitors can reduce the functional activity of D11Wsu47e. Aspirin achieves this through irreversible inhibition of both COX-1 and COX-2, while Ibuprofen does so by reversibly inhibiting these enzymes, suggesting a more temporary inhibition of D11Wsu47e activity. Similarly, Naproxen, Indomethacin, and Diclofenac function as non-selective COX inhibitors, also leading to reduced prostaglandin synthesis. Indomethacin's inhibition of COX may particularly impact prostaglandin synthesis, which in turn could inhibit the activity of D11Wsu47e.
In addition to these non-selective COX inhibitors, there are also COX-2 selective inhibitors like Celecoxib, Rofecoxib, Meloxicam, and Valdecoxib that can decrease prostaglandin production, which is possibly a critical component for the function of D11Wsu47e. Celecoxib and Rofecoxib selectively inhibit COX-2, which is primarily involved in the inflammatory response. This selectivity can lead to a targeted decrease in prostaglandin synthesis that could be essential for D11Wsu47e's function within inflammatory processes. Meloxicam, while preferentially inhibiting COX-2, also exhibits this ability to lower prostaglandin synthesis, thereby indirectly inhibiting D11Wsu47e. Valdecoxib, another selective COX-2 inhibitor, can contribute to the inhibition of D11Wsu47e by a similar reduction in prostaglandin levels. Piroxicam, another chemical in this list, acts as a COX inhibitor which may affect prostaglandin levels, potentially implicating in the inhibition of D11Wsu47e's enzymatic activity, contributing to the overall inhibition of this protein's function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetaminophen | 103-90-2 | sc-203425 sc-203425A sc-203425B | 25 g 100 g 500 g | $41.00 $61.00 $194.00 | 11 | |
Inhibits COX enzymes, which may decrease the production of prostaglandins that could be necessary for D11Wsu47e function. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Irreversibly inhibits COX-1 and COX-2 enzymes, potentially reducing prostaglandin synthesis required for D11Wsu47e activity. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Reversibly inhibits COX-1 and COX-2, lowering prostaglandin production which is possibly crucial for D11Wsu47e's activity. | ||||||
Naproxen | 22204-53-1 | sc-200506 sc-200506A | 1 g 5 g | $24.00 $41.00 | ||
Nonselectively inhibits COX activity, potentially decreasing prostaglandin levels necessary for D11Wsu47e function. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
COX inhibitor that could reduce prostaglandin synthesis, indirectly inhibiting the function of D11Wsu47e. | ||||||
Vioxx | 162011-90-7 | sc-208486 | 100 mg | $190.00 | 3 | |
Selective COX-2 inhibitor that may diminish prostaglandin production, indirectly inhibiting D11Wsu47e's function. | ||||||
Diclofenac Sodium | 15307-79-6 | sc-202136 sc-202136A | 5 g 25 g | $41.00 $128.00 | 4 | |
Non-selective COX inhibitor that could lower prostaglandin levels, thereby indirectly inhibiting D11Wsu47e function. | ||||||
Piroxicam | 36322-90-4 | sc-200576 sc-200576A | 1 g 5 g | $109.00 $376.00 | 2 | |
COX inhibitor that may reduce prostaglandin levels, potentially implicating in the inhibition of D11Wsu47e's enzymatic activity. | ||||||
Meloxicam | 71125-38-7 | sc-200626 sc-200626A sc-200626B | 20 mg 100 mg 500 mg | $36.00 $94.00 $156.00 | 3 | |
Preferentially inhibits COX-2, leading to a decrease in prostaglandin synthesis which could indirectly inhibit D11Wsu47e function. | ||||||